A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Aurigene Discovery Technologies Limited
University of Milano Bicocca
Lebanese University
Kineta Inc.
Provectus Pharmaceuticals
Blue Note Therapeutics
Assistance Publique - Hôpitaux de Paris
Weprom
TScan Therapeutics, Inc.
SpeciCare
Petra Pharma
Xuanwu Hospital, Beijing
Optimata Ltd.
SPGO Research Mannheim GmbH
The Cooper Health System
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Center, Korea